<DOC>
	<DOC>NCT02070679</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of vitamin E on preventing from incidence of contrast induced acute kidney injury (CI-AKI) in the patients who undergone coronary angiography.</brief_summary>
	<brief_title>Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Angina, Unstable</mesh_term>
	<mesh_term>Angina, Stable</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>1. All patients whon have either stable coronary artery disease (CAD) or recent acute coronary disease (ACS) and are scheduled for coronary angiography. 2. Patients who have eGFR ≤60 ml/min/1.73 m2 1. Allergy to contrast media 2. Cardiogenic shock 3. Pulmonary edema 4. Overt cardiac failure or left ventricular ejection fraction ≤ 30% 5. Acute kidney injury 6. The history of receiving contrast media for any medical diagnostic or therapeutic procedures during previous 5 days 7. The history of dialysis 8. Being pregnant 9. Having recent acute myocardial infarction 10. Taking antioxidants and nephrotoxic drugs including NSAID and ACEI on previous 2 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Alpha-tocopherol</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Contrast-Induced Acute Kidney Injury</keyword>
	<keyword>Coronary angiography</keyword>
</DOC>